Sublingual Dexmedetomidine as a Potential New Treatment for Agitation.

Autor:	Hsiao, John K.
Předmět:	DEXMEDETOMIDINE CLINICAL trials AGITATION (Psychology) AGITATED patients BIPOLAR disorder ANTIPSYCHOTIC agents BENZODIAZEPINES
Zdroj:	JAMA: Journal of the American Medical Association; 2/22/2022, Vol. 327 Issue 8, p723-725, 3p
Abstrakt:	The author discusses a study by S. H. Preskorn et al which reported findings from a clinical trial of a sublingual alpha-2 noradrenergic agonist dexmedetomidine to control agitation in patients with bipolar disorder. Topics include the limited use and mechanism of action of dexmedetomidine, its differences from antipsychotic drugs such as benzodiazepines, and the study's findings that sublingual dexmedetomidine reduced agitation in mild to moderately agitated patients with bipolar disoder.
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu